Shane R. Stecklein

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

Priyanka Sharma, Jennifer R. Klemp, Bruce F. Kimler et al. · Breast Cancer Research and Treatment · 2014 · 215 citations · Full text

Life Sciences, Genetics, Oncology +14

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder et al. · JAMA Oncology · 2023 · 164 citations · Full text

Medicine, Oncology, Pharmacology +17

BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation

Shane R. Stecklein, Easwari Kumaraswamy, Fariba Behbod et al. · Proceedings of the National Academy of Sciences · 2012 · 135 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Priyanka Sharma, Vandana G. Abramson, Anne O’Dea et al. · Clinical Cancer Research · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer

Matthew S. Ning, Vamsi Ahobila, Anuja Jhingran et al. · Gynecologic Oncology · 2017 · 78 citations

Medicine, Oncology, Radiation Oncology +14